What are the odds on her getting a shite result?
Anything possible of course.
Leslie Chong | CEO & Managing Director
Ms Chong has 24 years of oncology experience in Phase I – III of clinical program development, including leadership role involvement in two marketed oncology products. She was previously Senior Clinical Program Lead at Genentech, Inc., in San Francisco. Genentech is widely regarded as one of the world’s most successful biotech companies with a strong oncology franchise including the best-selling breast cancer drug Herceptin.
What are the odds on her getting a shite result? Anything...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
-0.002(2.90%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.7¢ | $1.445M | 21.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 2363454 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 14705 | 1 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.002 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.7¢ | 9797879 | ||
| Last updated 16.01pm 22/05/2024 ? | |||||
| IMU (ASX) Chart |